- Home
- BNTX vs STT Comparison
BNTX vs STT Comparison
Compare BNTX & STT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- STT
- Stock Information
- Founded
- BNTX 2008
- STT 1792
- Country
- BNTX Germany
- STT United States
- Employees
- BNTX N/A
- STT N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- STT Major Banks
- Sector
- BNTX Health Care
- STT Finance
- Exchange
- BNTX Nasdaq
- STT Nasdaq
- Market Cap
- BNTX 23.9B
- STT 27.7B
- IPO Year
- BNTX 2019
- STT N/A
- Fundamental
- Price
- BNTX $118.39
- STT $98.51
- Analyst Decision
- BNTX Strong Buy
- STT Hold
- Analyst Count
- BNTX 14
- STT 14
- Target Price
- BNTX $141.60
- STT $92.50
- AVG Volume (30 Days)
- BNTX 1.2M
- STT 1.8M
- Earning Date
- BNTX 11-04-2024
- STT 01-17-2025
- Dividend Yield
- BNTX N/A
- STT 3.09%
- EPS Growth
- BNTX N/A
- STT N/A
- EPS
- BNTX N/A
- STT 6.30
- Revenue
- BNTX $3,390,698,192.00
- STT $12,548,000,000.00
- Revenue This Year
- BNTX N/A
- STT N/A
- Revenue Next Year
- BNTX N/A
- STT $3.22
- P/E Ratio
- BNTX N/A
- STT $15.63
- Revenue Growth
- BNTX N/A
- STT 4.38
- 52 Week Low
- BNTX $76.53
- STT $70.20
- 52 Week High
- BNTX $131.49
- STT $99.50
- Technical
- Relative Strength Index (RSI)
- BNTX 57.96
- STT 66.08
- Support Level
- BNTX $101.02
- STT $94.57
- Resistance Level
- BNTX $121.80
- STT $99.50
- Average True Range (ATR)
- BNTX 5.86
- STT 1.27
- MACD
- BNTX 1.79
- STT 0.16
- Stochastic Oscillator
- BNTX 87.60
- STT 82.13
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $42 trillion in assets under custody and administration and $4.1 trillion assets under management as of Dec. 31, 2023, State Street operates globally in more than 100 geographic markets and employs more than 46,000 worldwide.